Stryker Corp (SYK)
336.85
+1.94
(+0.58%)
USD |
NYSE |
Apr 24, 16:00
336.88
+0.03
(+0.01%)
Pre-Market: 20:00
Stryker Cash from Investing (Quarterly): -152.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -152.00M |
| September 30, 2023 | -145.00M |
| June 30, 2023 | -533.00M |
| March 31, 2023 | -132.00M |
| December 31, 2022 | -162.00M |
| September 30, 2022 | 72.00M |
| June 30, 2022 | -152.00M |
| March 31, 2022 | -2.682B |
| December 31, 2021 | -314.00M |
| September 30, 2021 | -247.00M |
| June 30, 2021 | -202.00M |
| March 31, 2021 | -96.00M |
| December 31, 2020 | -4.352B |
| September 30, 2020 | -69.00M |
| June 30, 2020 | -117.00M |
| March 31, 2020 | -163.00M |
| December 31, 2019 | -719.00M |
| September 30, 2019 | -186.00M |
| June 30, 2019 | -247.00M |
| March 31, 2019 | -303.00M |
| December 31, 2018 | -1.628B |
| September 30, 2018 | -156.00M |
| June 30, 2018 | -224.00M |
| March 31, 2018 | -849.00M |
| December 31, 2017 | -460.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -815.00M |
| June 30, 2017 | -192.00M |
| March 31, 2017 | -146.00M |
| December 31, 2016 | -177.00M |
| September 30, 2016 | -102.00M |
| June 30, 2016 | -3.969B |
| March 31, 2016 | 57.00M |
| December 31, 2015 | -585.00M |
| September 30, 2015 | 315.00M |
| June 30, 2015 | 1.90B |
| March 31, 2015 | 326.00M |
| December 31, 2014 | -88.00M |
| September 30, 2014 | -424.00M |
| June 30, 2014 | -1.015B |
| March 31, 2014 | -351.00M |
| December 31, 2013 | -291.00M |
| September 30, 2013 | -368.00M |
| June 30, 2013 | -1.198B |
| March 31, 2013 | -360.00M |
| December 31, 2012 | -569.00M |
| September 30, 2012 | -428.00M |
| June 30, 2012 | 384.00M |
| March 31, 2012 | -123.00M |
| December 31, 2011 | -380.00M |
| September 30, 2011 | -497.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.352B
Minimum
Dec 2020
72.00M
Maximum
Sep 2022
-557.79M
Average
-163.00M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.053B |
| Haemonetics Corp | -268.94M |
| Abbott Laboratories | -824.00M |
| Zimmer Biomet Holdings Inc | -220.80M |
| Edwards Lifesciences Corp | 14.10M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.528B |
| Cash from Financing (Quarterly) | -286.00M |
| Free Cash Flow | 3.136B |
| Free Cash Flow Per Share (Quarterly) | 3.604 |
| Free Cash Flow to Equity (Quarterly) | 1.078B |
| Free Cash Flow to Firm (Quarterly) | 1.383B |
| Free Cash Flow Yield | 2.43% |